T
Tango Therapeutics, Inc. (TNGX)
NGM – Real Time Price. Currency in USD
31.47
+1.33 (4.41%)
At close: Jun 26, 2026, 4:00 PM EDT
30.85
-0.62 (-1.97%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
31.47
+1.33 (4.41%)
At close: Jun 26, 2026, 4:00 PM EDT
30.85
-0.62 (-1.97%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
| Name | Position |
|---|---|
| Dr. Adam S. Crystal M.D., Ph.D. | President of Research & Development |
| Dr. Antoni Ribas M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
| Dr. Barbara L. Weber M.D. | Founder & Executive Chair |
| Dr. Malte Peters M.D. | President, CEO & Director |
| Dr. William G. Kaelin Jr., M.D. | Founder & Member of Scientific Advisory Board |
| Mr. Jannik N. Andersen Ph.D. | Chief Scientific Officer |
| Mr. Matthew Gall M.B.A. | Chief Financial Officer |
| Ms. Daniella Beckman CPA | Executive Officer |
| Prof. Alan Ashworth FRS, Ph.D. | Founder & Member of Scientific Advisory Board |
| Date | Type | Document |
|---|---|---|
| 2026-06-23 | 8-K | d79260d8k.htm |
| 2026-06-10 | 8-K | d81492d8k.htm |
| 2026-06-08 | 8-K | d158334d8k.htm |
| 2026-06-04 | 8-K | d149262d8k.htm |
| 2026-05-13 | 8-K | tngx-20260513.htm |
| 2026-05-13 | 10-Q | tngx-20260331.htm |
| 2026-05-08 | 8-K | d102174d8k.htm |
| 2026-04-17 | DEFA14A | d93491ddefa14a.htm |
| 2026-04-17 | DEF 14A | tngx-20260416.htm |
| 2026-04-17 | ARS | d145279dars.pdf |